26 - World Journal of Gastroenterology
26 - World Journal of Gastroenterology
26 - World Journal of Gastroenterology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Pacifico L et al . Pediatric NAFLD and cardiovascular risk<br />
ated with insulin resistance over both the short and long<br />
term [101] . The issue <strong>of</strong> NAFLD and bariatric surgery in<br />
children is complex [71] . Though adolescents are increasingly<br />
undergoing surgical treatment <strong>of</strong> obesity, the guidelines for<br />
eligibility are not standardized [102] . In addition, children with<br />
a clinical diagnosis <strong>of</strong> NAFLD are different from those<br />
typically undergoing bariatric surgery [103] . Children with a<br />
clinical diagnosis <strong>of</strong> NAFLD tend to be younger and less<br />
obese than adolescents undergoing surgical treatment <strong>of</strong><br />
obesity [103] . Although several studies report resolution or<br />
improvement <strong>of</strong> comorbidities after bariatric surgery in<br />
adolescents [104,105] , liver outcome data are needed. In a series<br />
<strong>of</strong> 41 adolescents, Nadler et al [105] reported improvement in<br />
liver function enzymes 1 to 2 years after surgery.<br />
CONCLUSION<br />
The current body <strong>of</strong> evidence suggests that NAFLD is<br />
associated with a significantly greater overall mortality<br />
than in the general population, as well as with increased<br />
CVD prevalence, independently <strong>of</strong> classical atherosclerotic<br />
risk factors. These observations raise the possibility<br />
that NAFLD may be not only a marker but also an early<br />
mediator <strong>of</strong> atherosclerosis.<br />
Children with NAFLD may also be at a higher risk for<br />
atherosclerosis. Therefore, the rising prevalence <strong>of</strong> obesityrelated<br />
MetS and NAFLD in childhood may lead to a parallel<br />
increase in adverse cardiovascular outcomes. In children,<br />
the cardiovascular system remains plastic and damagereversible<br />
if early and appropriate interventions are established<br />
effectively. Therapeutic goals for NAFLD should address<br />
nutrition, physical activity and avoidance <strong>of</strong> smoking<br />
to prevent not only end-stage liver disease but also CVD.<br />
REFERENCES<br />
1 Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review<br />
article: epidemiology, pathogenesis and potential treatments<br />
<strong>of</strong> paediatric non-alcoholic fatty liver disease. Aliment<br />
Pharmacol Ther 2008; 28: 13-24<br />
2 Angulo P. Nonalcoholic fatty liver disease. N Engl J Med<br />
2002; 346: 1221-1231<br />
3 Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances<br />
in pediatric nonalcoholic fatty liver disease. Hepatology 2009;<br />
50: 1282-1293<br />
4 Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C,<br />
Behling C. Prevalence <strong>of</strong> fatty liver in children and adolescents.<br />
Pediatrics 2006; 118: 1388-1393<br />
5 Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci<br />
MP, Saviano MC, Brunetti F, Rubino A. Liver involvement<br />
in obese children. Ultrasonography and liver enzyme levels<br />
at diagnosis and during follow-up in an Italian population.<br />
Dig Dis Sci 1997; 42: 1428-1432<br />
6 Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F.<br />
Liver steatosis in juvenile obesity: correlations with lipid<br />
pr<strong>of</strong>ile, hepatic biochemical parameters and glycemic and<br />
insulinemic responses to an oral glucose tolerance test. Int J<br />
Obes Relat Metab Disord 2000; 24: 772-776<br />
7 Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum<br />
alanine aminotransferase activity in obese children. Acta<br />
Paediatr 1997; 86: 238-241<br />
8 Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK,<br />
Chan IH, Yin J, Lam CW, Fok TF, Nelson EA. Hepatic ste-<br />
WJG|www.wjgnet.com<br />
atosis in obese Chinese children. Int J Obes Relat Metab Disord<br />
2004; 28: 1257-1<strong>26</strong>3<br />
9 Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component<br />
<strong>of</strong> the metabolic syndrome. Arterioscler Thromb Vasc Biol<br />
2008; 28: 27-38<br />
10 Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G,<br />
Zenari L, Cigolini M, Falezza G, Arcaro G. Relations between<br />
carotid artery wall thickness and liver histology in<br />
subjects with nonalcoholic fatty liver disease. Diabetes Care<br />
2006; 29: 1325-1330<br />
11 Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza<br />
G. Non-alcoholic hepatic steatosis and its relation to increased<br />
plasma biomarkers <strong>of</strong> inflammation and endothelial<br />
dysfunction in non-diabetic men. Role <strong>of</strong> visceral adipose<br />
tissue. Diabet Med 2005; 22: 1354-1358<br />
12 Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L,<br />
Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S.<br />
Carotid artery intima-media thickness in nonalcoholic fatty<br />
liver disease. Am J Med 2008; 121: 72-78<br />
13 Targher G, Day CP, Bonora E. Risk <strong>of</strong> cardiovascular disease<br />
in patients with nonalcoholic fatty liver disease. N Engl<br />
J Med 2010; 363: 1341-1350<br />
14 Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD,<br />
Feldstein A, Angulo P. The natural history <strong>of</strong> nonalcoholic<br />
fatty liver disease: a population-based cohort study. <strong>Gastroenterology</strong><br />
2005; 129: 113-121<br />
15 Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist<br />
M, Bodemar G, Kechagias S. Long-term follow-up <strong>of</strong><br />
patients with NAFLD and elevated liver enzymes. Hepatology<br />
2006; 44: 865-873<br />
16 Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich<br />
T, Younossi ZM. Long-term follow-up <strong>of</strong> patients with nonalcoholic<br />
fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238<br />
17 Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G,<br />
Marmur J, Hultcrantz R. Decreased survival <strong>of</strong> subjects with<br />
elevated liver function tests during a 28-year follow-up.<br />
Hepatology 2010; 51: 595-602<br />
18 Bland J, Skordalaki A, Emery JL. Early intimal lesions in the<br />
common carotid artery. Cardiovasc Res 1986; 20: 863-868<br />
19 Stary HC. Lipid and macrophage accumulations in arteries<br />
<strong>of</strong> children and the development <strong>of</strong> atherosclerosis. Am J<br />
Clin Nutr 2000; 72: 1297S-1306S<br />
20 Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan<br />
SR, Cresanta JL, Williamson GD, Webber LS, Berenson<br />
GS. Relation <strong>of</strong> serum lipoprotein levels and systolic blood<br />
pressure to early atherosclerosis. The Bogalusa Heart Study.<br />
N Engl J Med 1986; 314: 138-144<br />
21 Wissler RW, Strong JP. Risk factors and progression <strong>of</strong> atherosclerosis<br />
in youth. PDAY Research Group. Pathological<br />
Determinants <strong>of</strong> Atherosclerosis in Youth. Am J Pathol 1998;<br />
153: 1023-1033<br />
22 Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy<br />
RE, Wattigney WA. Association between multiple cardiovascular<br />
risk factors and atherosclerosis in children and<br />
young adults. The Bogalusa Heart Study. N Engl J Med 1998;<br />
338: 1650-1656<br />
23 Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T,<br />
Mäki-Torkko, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T,<br />
Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood<br />
and carotid artery intima-media thickness in adulthood:<br />
the Cardiovascular Risk in Young Finns Study. JAMA 2003;<br />
290: 2277-2283<br />
24 Magnussen CG, Koskinen J, Chen W, Thomson R, Schmidt<br />
MD, Srinivasan SR, Kivimäki M, Mattsson N, Kähönen M,<br />
Laitinen T, Taittonen L, Rönnemaa T, Viikari JS, Berenson GS,<br />
Juonala M, Raitakari OT. Pediatric metabolic syndrome predicts<br />
adulthood metabolic syndrome, subclinical atherosclerosis,<br />
and type 2 diabetes mellitus but is no better than body mass<br />
index alone: the Bogalusa Heart Study and the Cardiovascular<br />
Risk in Young Finns Study. Circulation 2010; 122: 1604-1611<br />
25 Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M,<br />
3088 July 14, 2011|Volume 17|Issue <strong>26</strong>|